Table 2.

Apheresis products composition and CD4-CD8 cell selection.

Pat. ID	Disease	Apheresis products					CD4-CD8 selection
		WBC (×109)	Lymph (×109)	CD3+ (%)*	CD4+ (%)*	CD8+ (%)*	Total cell number (×106)
T01	Adult ALL	7.15	6.40	24.80	12.60	10.70	960
T02	NHL	3.31	1.56	32.50	11.40	19.80	1,200
T03	Pediatric ALL	4.59	3.50	49.38	22.67	26.71	1,580
T04	NHL	4.04	0.85	13.50	6.60	6.20	488
T05	NHL	7.71	4.23	30.00	12.10	15.50	1,800
T06	Adult ALL	3.64	3.19	28.80	10.60	16.20	720
T07	Adult ALL	4.91	3.84	29.00	4.40	19.80	1,900
T08	CLL	2.88	2.30	19.70	8.80	10.10	1,560
T09	Pediatric ALL	4.27	3.24	21.50	11.30	8.80	1,442
T10	Adult ALL	1.00	0.72	15.30	7.90	6.10	350
T11	Adult ALL	2.08	0.98	13.90	7.90	4.40	360
T12	Pediatric ALL	8.40	6.21	2.20	1.70	0.50	150
T13	Adult ALL	1.29	0.64	26.90	8.40	15.60	250
T14	Adult ALL	3.22	2.31	38.90	17.80	18.00	2,160
T15	Adult ALL	2.88	1.28	26.10	8.70	14.50	1,050
T16	Pediatric ALL	1.98	1.22	22.60	4.80	15.90	400
T17	Adult ALL	8.55	2.82	27.90	7.40	19.20	1,400
T19	Pediatric ALL	1.09	0.20	22.50	12.80	7.50	250
T20	Adult ALL	3.73	2.23	28.60	7.20	20.70	760
T21	Pediatric ALL	4.50	2.20	36.20	18.60	14.20	400
T22	Adult ALL	8.37	3.16	42.00	21.40	19.50	750
T24	Adult ALL	25.85	22.00	4.10	1.20	0.70	200
T25	Adult ALL	0.83	0.46	32.50	5.50	25.70	1,520
T26	Pediatric ALL	0.84	0.51	6.50	1.40	4.60	200
T27	Adult ALL	0.33	0.10	10.00	3.30	6.10	50
T30	Adult ALL	2.06	1.48	46.50	13.20	28.80	871
T32	Adult ALL	2.23	0.69	52.00	19.30	27.40	2,000
T34	NHL	6.71	3.54	23.50	12.60	9.70	993

^*% of cells over WBC.